Kenneth L. Horton

2014

In 2014, Kenneth L. Horton earned a total compensation of $9.9M as Former EVP & Chief Legal Officer at Vertex Pharmaceuticals, a 118% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$279,000
Option Awards$3,418,455
Salary$465,000
Stock Awards$5,741,425
Other$3,253
Total$9,907,133

Horton received $5.7M in stock awards, accounting for 58% of the total pay in 2014.

Horton also received $279K in non-equity incentive plan, $3.4M in option awards, $465K in salary and $3.3K in other compensation.

Rankings

In 2014, Kenneth L. Horton's compensation ranked 523rd out of 13,032 executives tracked by ExecPay. In other words, Horton earned more than 96.0% of executives.

ClassificationRankingPercentile
All
523
out of 13,032
96th
Division
Manufacturing
178
out of 4,966
96th
Major group
Chemicals And Allied Products
60
out of 1,686
96th
Industry group
Drugs
49
out of 1,365
96th
Industry
Pharmaceutical Preparations
46
out of 1,043
96th
Source: SEC filing on April 30, 2015.

Horton's colleagues

We found four more compensation records of executives who worked with Kenneth L. Horton at Vertex Pharmaceuticals in 2014.

2014

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2014

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2014

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2014

Jeffrey Chodakewitz

Vertex Pharmaceuticals

Chief Medical Officer

You may also like